mercredi 19 septembre 2018

Onco Actu du 19 septembre 2018

1. Biologie

Why Your DNA Is Still Uncharted Territory [NY Times]

1.1 Biologie - Gènes

Researchers resolve decades-old mystery about the most commonly mutated gene in cancer [Broad Institute]

2.11 Etiologie - Alimentation

Eating junk food tied to higher risk of numerous cancers [CNN]

2.6 Etiologie - Environnement

Bayer's Monsanto asks U.S. court to toss $289 million glyphosate verdict [Reuters]

3.1.1 Prévention - Tabac - e-cigs

FDA launches new, comprehensive campaign to warn kids about the dangers of e-cigarette use as part of agency’s Youth Tobacco Prevention Plan, amid evidence of sharply rising use among kids [FDA]

4.9 Dép., diag. & prono. - Sein

You Might Want Artificial Intelligence Reading Your Next Mammogram [Forbes]

5.12.5 Immunothérapies - Pharma

European Medicines Agency Validates Bristol-Myers Squibb’s Application for Empliciti (elotuzumab) Plus Pomalidomide and Low-Dose Dexamethasone in Patients with Multiple Myeloma [BMS]

Allogene spells out its interest in Cellectis [Vantage]

5.2.3 Pharma - économie

Clovis CEO Patrick Mahaffy settles up on SEC charges of lying about the roci data — and it won’t cost much [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

Recent FDA Approvals Signal More Progress Against Cancer [Cancer Research Catalyst]

5.4 Traitements - Economie

Drug combo for advanced skin cancer approved on NHS in England [Cancer Research UK]

6.7.1 IA/bioinformatique

Pathologists meet their match in tumour-spotting algorithm [Nature]

6.7.2 Applis

Roche tackles clinical trial matching challenge [FierceBiotech]

Roche Introduces Clinical Trial Matching Feature in Navify Tumor Board Solution [Genome Web]

6.9 Controverses

Boilover: The Cochrane HPV Vaccine Fire Isn’t Really About the Evidence – but it’s Critical to Science [Absolutely Maybe]